e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 13

Mycophenolic acid pharmacogenomics in kidney transplantation

Fabiana Dalla Vecchia Genvigir; Álvaro Cerda; Thiago Dominguez Crespo Hirata; Mário Hiroyuki Hirata; Rosário Dominguez Crespo Hirata · 2020 · Journal of Translational Genetics and Genomics

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Mycophenolic acid (MPA) is a potent antiproliferative drug prescribed to prevent acute rejection in kidney transplantation. MPA reversibly inhibits the enzymes involved in the synthesis of guanosine nucleotides, thus preventing DNA replication of immune cells. Consequently, the repression of both cell and humoral immunity induces renal allograft tolerance. MPA is an effective and safe immunosuppressive drug, but some patients show variability in drug concentration, acute rejection, graft dysfunction, or MPA-related adverse events. Although the pharmacogenomics of immunosuppressive drugs has be

Abstract by Fabiana Dalla Vecchia Genvigir; Álvaro Cerda; Thiago Dominguez Crespo Hirata; Mário Hiroyuki Hirata; Rosário Dominguez Crespo Hirata, Journal of Translational Genetics and Genomics (2020) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.20517/jtgg.2020.37